Mid-Day Breakouts Report - Thursday, February 5th, 2015

<<<Previous Mid Day Report	Next Mid Day Report >>>
<<<Previous After Market Report	Next After Market Report >>>

You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Sunday, September 15, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

MIDDAY BREAKOUTS REPORT - THURSDAY, FEBRUARY 5TH, 2015
Previous Mid Day Report Next Mid Day Report >>>

DOW 17831 157.98 (0.89%) | NASDAQ 4748.04 31.34 (0.66%) | S&P 500 2056.85 15.33 (0.75%)

Time of Screening : 2/5/2015 12:03:34 PM Report Released : 2/5/2015 1:00:01 PM
Price is: Above 52W High and Less Than 52W High but within 8% of the 52 Week High
Volume Is: At least 75% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page

Symbol/Exchange Company Name Industry Group	PRICE	CHANGE (%Change)	Day High	Volume (% DAV) (50 DAV)	52 Wk Hi % From Hi	Date Featured	Price Featured	Pivot Point
Symbol/Exchange Company Name Industry Group	PRICE	CHANGE (%Change)	Day High	Volume (% DAV) (50 DAV)	52 Wk Hi % From Hi	Date Featured	Price Featured	Max Buy
NXPI - NASDAQ Nxp Semiconductors N V	$78.81	-0.94 -1.18%	$80.75	3,011,824 98.49% of 50 DAV 50 DAV is 3,058,000	$82.76 -4.77%	1/5/2015	$76.43	PP = $78.44 MB = $82.36
Most Recent Note - 2/5/2015 12:42:56 PM Y - Churned above average volume but made no meaningful price progress in recent weeks, a sign of distributional pressure. No resistance remains to hinder its progress. Its 50 DMA line ($77.12) acted as support recently, where a violation would raise concerns and trigger a technical sell signal. >>> The latest Featured Stock Update with an annotated graph appeared on 1/22/2015. Click here.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
VRX - NYSE Valeant Pharmaceuticals	$161.10	+0.23 0.14%	$162.24	1,525,870 79.47% of 50 DAV 50 DAV is 1,920,000	$165.69 -2.77%	1/5/2015	$144.84	PP = $149.90 MB = $157.40
Most Recent Note - 2/5/2015 12:54:11 PM G - Holding its ground following a "negative reversal" on 2/03/15, and it is extended from any sound base. Its 50 DMA line ($148.95) defines near-term support to watch. >>> The latest Featured Stock Update with an annotated graph appeared on 1/23/2015. Click here.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

Symbol - Exchange - Industry Group Company Name	Last	Chg	Day High	52 WK Hi	% From Hi	Volume % DAV	DAV
AGN - NYSE - DRUGS - Drug Manufacturers - Other Allergan Inc	$225.44	+6.02 2.74%	$225.66	$228.43	-1.31%	2,186,064 96.81%	2,258,000
Most Recent Note for AGN - 2/5/2015 12:07:39 PM Found support above its 50 DMA line while consolidating since a gap up on 11/17/14 news it will be acquired by Actavis Plc (ACT) for $66 Billion. Reported earnings +66% on +13% sales revenues for the Dec '14 quarter, its 2nd consecutive quarterly earnings comparison well above the +25% minimum guideline (C criteria).
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
BRLI - NASDAQ - HEALTH SERVICES - Medical Laboratories & Researc Bio Reference Labs Inc	$33.80	-0.66 -1.92%	$34.62	$34.83	-2.96%	247,833 104.13%	238,000
Most Recent Note for BRLI - 2/5/2015 12:10:10 PM Reported earnings +65% on +18% sales revenues for the Oct '14 quarter, but fundamental concerns remain. Perched near its 52-week high today, and it made gradual progress since last noted with caution in the 12/26/14 mid-day report.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CBPO - NASDAQ - DRUGS - Biotechnology China Biologic Products	$68.25	+0.78 1.16%	$68.55	$71.27	-4.24%	65,594 100.91%	65,000
Most Recent Note for CBPO - 2/5/2015 12:11:58 PM Still holding its ground in a tight trading range, consolidating near its 52-week high and finding support near its 50 DMA line. Prior mid-day reports cautioned members - "Reported earnings +45% on +30% sales revenues for the Sep '14 quarter, and earnings increases have been near or above the +25% minimum (C criteria). Completed a new Public Offering on 6/27/14. Following a downturn in FY '10 earnings its annual earnings (A criteria) have been improving."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CMG - NYSE - LEISURE - Restaurants Chipotle Mexican Grill	$672.91	-3.09 -0.46%	$679.99	$727.97	-7.56%	338,596 81.59%	415,000
Most Recent Note for CMG - 2/5/2015 12:13:25 PM Gapped down on the prior session undercutting its 50 DMA line, also completing a bearish "island reversal" pattern following a gap up when noted with caution in the 1/08/15 mid-day report. Reported +52% earnings on +27% sales revenues for the Dec '14 quarter. Fundamental concerns remain, however that marked its 2nd consecutive quarter with earning increasing above the +25% minimum (C criteria). Its annual earnings (A criteria) history has been very strong and steady.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
COST - NASDAQ - RETAIL - Discount, Variety Stores Costco Wholesale Corp	$149.56	-1.36 -0.90%	$151.10	$156.85	-4.65%	3,858,523 156.66%	2,463,000
Most Recent Note for COST - 2/5/2015 12:14:24 PM Gapped down today, retreating from its new 52-week high following an impressive streak of volume-driven gains. Prior mid-day reports cautioned members - "Reported earnings +17% on +7% sales for the Nov '14 quarter, below the +25% minimum guideline (C criteria). Prior quarterly comparisons also showed sub par sales revenues and earnings growth leaving fundamental concerns."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
DATA - NYSE - HEALTH SERVICES - Medical Laboratories & Researc Tableau Software Cl A	$96.72	+12.51 14.86%	$98.41	$102.37	-5.52%	2,648,159 360.29%	735,000
Most Recent Note for DATA - 2/5/2015 12:17:53 PM Gapped up today hitting a new 52-week high. Reported +75% sales revenues and a +110% earnings increase for the Dec '14 quarter. Fundamental concerns remain because its prior quarterly and annual earnings (C and A criteria) history has not been strong and steady.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
DIS - NYSE - MEDIA - Entertainment - Diversified Walt Disney Company	$102.18	+0.90 0.89%	$102.84	$101.94	0.24%	6,570,694 89.06%	7,378,000
Most Recent Note for DIS - 2/5/2015 12:20:23 PM Gapped up on the prior session for a considerable volume-driven gains and it is hitting another new 52-week high today, adding to a streak of volume-driven gains. Goliath Media - Diversified firm reported earnings +22% on +9% sales revenues for the Dec '14 quarter. Prior quarters were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
FLWS - NASDAQ - INTERNET - Internet Software & Services One-800Flowers.com Cl A	$9.47	-0.10 -1.04%	$9.80	$9.59	-1.25%	290,733 120.64%	241,000
Most Recent Note for FLWS - 2/5/2015 12:21:34 PM Touched a new 52-week high today. Rallied with above average volume behind a streak of gains from below its 50 DMA line. Reported earnings +207% on +101% sales revenues for the Dec '14 quarter. Prior quarters showed sub par sales growth and erratic earnings. Noted in prior mid-day reports with caution - "Earnings history is not a match with the fundamental guidelines (C and A criteria) of the fact-based investment system. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Sales revenues growth has been lackluster, not indicative of great demand for a hot new (N criteria) product or service."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
GPK - NYSE - CONSUMER NON-DURABLES - Packaging & Containers Graphic Packaging Hldg	$15.18	+0.49 3.34%	$16.14	$14.95	1.54%	4,203,777 135.69%	3,098,000
Most Recent Note for GPK - 2/5/2015 12:23:13 PM Gapped up and hit another new 52-week high today, rallying with no resistance due to overhead supply. The 1/26/15 mid-day report noted - "Reported earnings +42% on -10% sales revenues for the Sep '14 quarter. Completed Secondary Offerings on 5/21/14, 2/13/14, 11/21/13, 6/03/13, 3/21/13 and on 12/12/12. Waning quarterly sales revenues indicates no great demand for new (N criteria) products or services. Low-priced stocks are discouraged from consideration under the fact-based system unless all key criteria are solidly satisfied."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
GPX - NYSE - DIVERSIFIED SERVICES - Education & Training Services G P Strategies Corp	$34.15	+0.22 0.65%	$34.60	$34.95	-2.29%	62,238 85.26%	73,000
Most Recent Note for GPX - 2/5/2015 12:24:03 PM Consolidating above support at its 50 DMA line, it endured more distributional pressure in recent weeks. Made limited headway since noted in the 12/12/14 mid-day report with caution - "Reported earnings +16% on +9% sales revenues for the Sep '14 quarter, below the +25% minimum earnings guideline (C criteria). Fundamental concerns remain. It was dropped from the Featured Stocks list on 12/05/12."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
HDB - NYSE - BANKING - Foreign Regional Banks H D F C Bank Ltd Adr	$58.12	+0.36 0.62%	$58.69	$62.10	-6.41%	4,325,683 386.57%	1,119,000
Most Recent Note for HDB - 2/5/2015 12:26:10 PM Retreated from its 52-week high with 3 consecutive volume-driven losses last week, then it proposed a new Public Offering this week. Noted with caution in prior mid-day reports - "Prior resistance in the $54 area defines near-term support to watch above its 50 DMA line. Reported earnings +23% on +18% sales revenues for the Sep '14 quarter and fundamental concerns remain. Quarterly earnings growth has been below the +25% minimum earnings guideline (C criteria). This India-based financial institution has shown sub par sales revenues increases. It survived but failed to impress since dropped from the Featured Stocks list on 1/17/08."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
HELE - NASDAQ - CONSUMER DURABLES - Appliances Helen Of Troy Ltd	$77.09	-0.78 -1.00%	$79.18	$78.60	-1.92%	170,898 83.77%	204,000
Most Recent Note for HELE - 2/5/2015 12:27:36 PM Held its ground and hit another new 52-week high today. There was a considerable gap up gain on 1/09/15, but fundamental concerns remain. Prior mid-day reports cautioned members - "Showed a great earnings increase in the Nov '14 quarter, but prior quarterly sales revenues and earnings growth has not been strong and steady."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
LB - NYSE - ELECTRONICS - Scientific & Technical Instrum L Brands Inc	$91.72	+5.21 6.02%	$91.82	$87.80	4.46%	1,688,699 97.78%	1,727,000
Most Recent Note for LB - 2/5/2015 12:29:46 PM Gapped up today hitting a new 52-week high. Found prompt support at its 50 DMA line. Noted with caution in prior mid-day reports- "Quarterly results through Oct '14 showed sub par sales revenues growth and its earnings history has not been strong and steady."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
LXFT - NYSE - Comp Sftwr-Spec Enterprs Luxoft Holding Inc Cl A	$41.63	+1.03 2.54%	$41.64	$43.57	-4.45%	184,872 84.80%	218,000
Most Recent Note for LXFT - 2/5/2015 12:31:01 PM Consolidating above support at its 50 DMA line and tallying a 3rd consecutive gain. Last noted with caution in the 12/11/14 mid-day report - "Reported earnings +23% on +28% sales revenues for the Sep '14 quarter, and fundamental concerns remain. Quarterly and annual earnings history (C and A criteria) has not been strong and steady."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
MCK - NYSE - WHOLESALE - Drugs Wholesale Mckesson Corp	$215.64	+4.80 2.28%	$216.49	$222.93	-3.27%	856,066 90.40%	947,000
Most Recent Note for MCK - 2/5/2015 12:32:54 PM Perched near its 52-week high, it found support at its 50 DMA line during its recent consolidation. Last noted with caution in the 12/09/14 mid-day report - "It has a steady annual earnings (A criteria) history, however quarterly earnings increases have not been strong and steady and sales revenues increases have been sub par."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
MNK - NYSE - Medical-Generic Drugs Mallinckrodt Plc	$108.29	+2.46 2.32%	$114.70	$109.74	-1.32%	1,175,514 87.86%	1,338,000
Most Recent Note for MNK - 2/5/2015 12:36:40 PM Off earlier highs after hitting a new 52-week high today with a considerable volume-driven gain. Reported earnings +109% on +60% sales revenues for the Dec '14 quarter, its 3rd consecutive quarter with earnings above the +25% minimum guideline (C criteria), however fundamental concerns remain. Found support at its 50 DMA line and made gradual progress since noted in the 11/26/14 mid-day report with caution - "Showed strong earnings increases in the Jun and Sep '14 quarters but prior quarterly and annual (C and A criteria) earnings and sales revenues history has not been strong and steady."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
MPWR - NASDAQ - ELECTRONICS - Semiconductor - Specialized Monolithic Power Systems	$47.90	+0.10 0.21%	$50.30	$50.66	-5.45%	181,564 77.26%	235,000
Most Recent Note for MPWR - 2/5/2015 12:41:39 PM Slumped back below its 50 DMA line after early gains today challenged its 52-week high. Recent quarterly comparisons through Dec '14 showed earnings increases above the +25% minimum guideline (C criteria). Rebounded and wedged to new highs since last noted with caution in the 10/07/14 mid-day report - "Its erratic annual earnings (A criteria) history does not match the fact-based investment system's guidelines. It survived but failed to impress since dropped from the Featured Stocks list on 9/5/08."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
OMCL - NASDAQ - COMPUTER HARDWARE - Computer Based Systems Omnicell Inc	$33.95	+0.84 2.54%	$34.15	$35.02	-3.06%	140,403 77.57%	181,000
Most Recent Note for OMCL - 2/5/2015 12:44:46 PM Hit a new 52-week high on the prior session and today it is tallying a 3rd consecutive volume-driven gain. The 2/04/15 mid-day report cautioned members - "Reported earnings +34% on +15% sales revenues for the Dec '14 quarter. Prior quarterly earnings increases failed to satisfy the C criteria (+25% minimum). Annual earnings (A criteria) history has been improving following a downturn in FY '08 and '09. It survived but failed to impress since dropped from the Featured Stocks list on 11/10/07."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ORLY - NASDAQ - RETAIL - Auto Parts Stores O Reilly Automotive Inc	$212.66	+19.95 10.35%	$214.15	$196.80	8.06%	1,134,338 151.25%	750,000
Most Recent Note for ORLY - 2/5/2015 12:46:41 PM Gapped up today hitting new 52-week and all-time highs. Reported earnings +26% on +9% sales revenues for the Dec '14 quarter. Prior comparisons were below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Annual earnings (A criteria) history has been strong.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
SERV - NYSE - DIVERSIFIED SERVICES - Business/Management Services ServiceMaster Global Holdings, Inc	$29.36	-0.41 -1.36%	$29.67	$30.33	-3.21%	6,516,086 1,217.96%	535,000
Most Recent Note for SERV - 2/5/2015 12:48:00 PM Perched at its 52-week high today after pricing a Secondary Offering. Found support while recently consolidating above prior highs in the $25 area and near its 50 DMA line. Noted with caution in prior mid-day reports - "Earnings increases in quarterly comparisons through Sep '14 have been strong but with sub par sales revenues increases in the +4-8% range. Limited history is a concern since its $17 IPO on 6/26/14."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
SIMO - NASDAQ - ELECTRONICS - Semiconductor - Specialized Silicon Motion Tech Ads	$29.67	+0.92 3.20%	$29.86	$28.99	2.35%	682,144 127.98%	533,000
Most Recent Note for SIMO - 2/5/2015 12:49:32 PM Hitting a new 52-week high with today's 3rd consecutive gain. Tallied a streak of volume-driven gains from support at its 50 DMA line. Prior mid-day reports cautioned members - "Reported earnings +60% on +53% sales revenues for the Dec '14 quarter, its 3rd consecutive quarterly comparison with earnings above the +25% minimum guideline. Downturn in FY '13 earnings (A criteria)is a flaw with respect to the fundamental guidelines of the fact-based investment system. It survived but failed to impress since dropped from the Featured Stocks list on 7/26/07."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
UA - NYSE - CONSUMER NON-DURABLES - Textile - Apparel Clothing Under Armour Inc Cl A	$73.00	-0.57 -0.77%	$76.54	$73.95	-1.28%	6,293,395 294.36%	2,138,000
Most Recent Note for UA - 2/5/2015 12:52:34 PM Touched new 52-week and all-time highs today then reversed into the red. Reported earnings +33% on +31% sales revenues for the Dec '14 quarter, an improvement after the 2 prior quarterly comparisons had earnings increases below the +25% minimum guideline. Found support above its 200 DMA line during its consolidation since dropped from the Featured Stocks list on 10/01/14 based on fundamental and technical weakness.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
WX - NYSE - DRUGS - Drug Manufacturers - Other Wuxi Pharmatech Inc Ads	$40.21	+0.25 0.61%	$40.50	$41.34	-2.75%	281,852 76.59%	368,000
Most Recent Note for WX - 2/5/2015 12:55:33 PM No resistance remains due to overhead supply and it is perched at its high, holding its ground stubbornly following recent volume-driven gains. The 2/02/15 mid-day report cautioned members - "Went through a long consolidation since noted with caution in the 3/13/14 mid-day report. Reported earnings +15% on +18% sales revenues for the Dec '14 quarter, marking its 3rd straight comparison below the +25% minimum earnings guideline (C criteria). This Chinese Medical - Research Equipment/Services firm's earnings history is not a match with the fact-based investment system's guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ZBRA - NASDAQ - COMPUTER HARDWARE - Computer Peripherals Zebra Tech Corp Cl A	$87.40	+0.90 1.04%	$87.44	$86.70	0.81%	356,853 80.55%	443,000
Most Recent Note for ZBRA - 2/5/2015 12:59:40 PM Hitting new 52-week highs today. Managed an impressive rebound after a slump below its 200 DMA line since last noted with caution in the 8/05/14 mid-day report. Reported earnings +21% on +15% sales revenues for the Dec '14 quarter, below the +25% minimum guideline (C criteria). Annual earnings (A criteria) have been improving since a downturn in FY '08 and '09.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

THESE ARE NOT BUY RECOMMENDATIONS! Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time. Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

We appreciate any feedback members may wish to send via the inquiry form here.